201 related articles for article (PubMed ID: 37504304)
1. Identification of a Novel ERK5 (MAPK7) Inhibitor, MHJ-627, and Verification of Its Potent Anticancer Efficacy in Cervical Cancer HeLa Cells.
Hwang J; Moon H; Kim H; Kim KY
Curr Issues Mol Biol; 2023 Jul; 45(7):6154-6169. PubMed ID: 37504304
[TBL] [Abstract][Full Text] [Related]
2. Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy.
Tubita A; Lombardi Z; Tusa I; Dello Sbarba P; Rovida E
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023850
[TBL] [Abstract][Full Text] [Related]
3. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
Squires MS; Nixon PM; Cook SJ
Biochem J; 2002 Sep; 366(Pt 2):673-80. PubMed ID: 12069688
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
Gavine PR; Wang M; Yu D; Hu E; Huang C; Xia J; Su X; Fan J; Zhang T; Ye Q; Zheng L; Zhu G; Qian Z; Luo Q; Hou YY; Ji Q
BMC Cancer; 2015 Jun; 15():454. PubMed ID: 26040563
[TBL] [Abstract][Full Text] [Related]
5. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
[TBL] [Abstract][Full Text] [Related]
6. ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion.
Rovida E; Spinelli E; Sdelci S; Barbetti V; Morandi A; Giuntoli S; Dello Sbarba P
J Immunol; 2008 Mar; 180(6):4166-72. PubMed ID: 18322228
[TBL] [Abstract][Full Text] [Related]
7. Impact of ERK5 on the Hallmarks of Cancer.
Stecca B; Rovida E
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901834
[TBL] [Abstract][Full Text] [Related]
8. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus.
Kamakura S; Moriguchi T; Nishida E
J Biol Chem; 1999 Sep; 274(37):26563-71. PubMed ID: 10473620
[TBL] [Abstract][Full Text] [Related]
9. The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
Tusa I; Gagliardi S; Tubita A; Pandolfi S; Menconi A; Lulli M; Dello Sbarba P; Stecca B; Rovida E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681917
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.
Fulford L; Milewski D; Ustiyan V; Ravishankar N; Cai Y; Le T; Masineni S; Kasper S; Aronow B; Kalinichenko VV; Kalin TV
Sci Signal; 2016 May; 9(427):ra48. PubMed ID: 27165781
[TBL] [Abstract][Full Text] [Related]
11. Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin.
Charlson AT; Zeliadt NA; Wattenberg EV
Toxicol Appl Pharmacol; 2009 Dec; 241(2):143-53. PubMed ID: 19716839
[TBL] [Abstract][Full Text] [Related]
12. ERK5: structure, regulation and function.
Nithianandarajah-Jones GN; Wilm B; Goldring CE; Müller J; Cross MJ
Cell Signal; 2012 Nov; 24(11):2187-96. PubMed ID: 22800864
[TBL] [Abstract][Full Text] [Related]
13. The significance of ERK5 catalytic-independent functions in disease pathways.
Le NT
Front Cell Dev Biol; 2023; 11():1235217. PubMed ID: 37601096
[TBL] [Abstract][Full Text] [Related]
14. Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer.
Bhatt AB; Wright TD; Barnes V; Chakrabarty S; Matossian MD; Lexner E; Ucar DA; Miele L; Flaherty PT; Burow ME; Cavanaugh JE
Transl Oncol; 2021 Jun; 14(6):101046. PubMed ID: 33761370
[TBL] [Abstract][Full Text] [Related]
15. ERK5 kinase activity is dispensable for cellular immune response and proliferation.
Lin EC; Amantea CM; Nomanbhoy TK; Weissig H; Ishiyama J; Hu Y; Sidique S; Li B; Kozarich JW; Rosenblum JS
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11865-11870. PubMed ID: 27679845
[TBL] [Abstract][Full Text] [Related]
16. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
[TBL] [Abstract][Full Text] [Related]
17. Activity assays for extracellular signal-regulated kinase 5.
Nakamura K; Johnson GL
Methods Mol Biol; 2010; 661():91-106. PubMed ID: 20811978
[TBL] [Abstract][Full Text] [Related]
18. The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells.
Devost D; Zingg HH; Hébert TE
Cell Signal; 2022 Feb; 90():110211. PubMed ID: 34902542
[TBL] [Abstract][Full Text] [Related]
19. MAPK signalling: ERK5 versus ERK1/2.
Nishimoto S; Nishida E
EMBO Rep; 2006 Aug; 7(8):782-6. PubMed ID: 16880823
[TBL] [Abstract][Full Text] [Related]
20. Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.
Erazo T; Moreno A; Ruiz-Babot G; Rodríguez-Asiain A; Morrice NA; Espadamala J; Bayascas JR; Gómez N; Lizcano JM
Mol Cell Biol; 2013 Apr; 33(8):1671-86. PubMed ID: 23428871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
